摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-benzyl-7-hydroxy-8-methoxy-2,3,4,5-tetrahydro-2-benzazepine | 253135-14-7

中文名称
——
中文别名
——
英文名称
2-benzyl-7-hydroxy-8-methoxy-2,3,4,5-tetrahydro-2-benzazepine
英文别名
2-benzyl-8-methoxy-2,3,4,5-tetrahydro-1H-benzo[c]azepin-7-ol;2-Benzyl-8-methoxy-1,3,4,5-tetrahydro-2-benzazepin-7-ol
2-benzyl-7-hydroxy-8-methoxy-2,3,4,5-tetrahydro-2-benzazepine化学式
CAS
253135-14-7
化学式
C18H21NO2
mdl
——
分子量
283.37
InChiKey
PDDCWQCIBRIMRI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    21
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    32.7
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • COMPOUND
    申请人:Jourdan Fabrice
    公开号:US20100222299A1
    公开(公告)日:2010-09-02
    The present invention involves tetrahydroisoquinoline compounds and their use in the inhibition and/or prevention of tumor growth.
    本发明涉及四氢异喹啉化合物及其在抑制和/或预防肿瘤生长中的应用。
  • TETRAHYDROISOQUINOLINES AS TUMOUR GROWTH INHIBITORS
    申请人:Sterix Limited
    公开号:EP2155192A2
    公开(公告)日:2010-02-24
  • US8394825B2
    申请人:——
    公开号:US8394825B2
    公开(公告)日:2013-03-12
  • [EN] COMPOUND<br/>[FR] COMPOSÉ
    申请人:STERIX LTD
    公开号:WO2008117061A2
    公开(公告)日:2008-10-02
    [EN] The present invention provides a compound of Formula (I) or Formula (Il) wherein A is selected from CR10R11, -S(=O)2-, -NR12-,and C=O, wherein R10 and R11 independently selected from H, -OH, hydrocarbyl, -CN, -NO2, and halogens, R12 is selected from H and hydrocarbyl; B is selected from (CR13R14)1-3, C=O, CR15R16C=O, -S(=O)2-, -NR17- and -NR18-C(=O)-, wherein each of R13, R14, R15 and R16 is independently selected from H, -OH, hydrocarbyl, -CN, -NO2, and halogens, R17 and R18 are independently selected from H and hydrocarbyl; R1 is selected from OH, O-hydrocarbyl, O-heterohydrocarbyl, -SO2-hydrocarbyl, -CH=CH2, halogen, -OSO2NR19R20, -C(=O)-NR21R22, -NR23-C(=O)H and -NR35R36; wherein each of R19, R20, R21, R22, R23, R35 and R36 is independently is selected from H and hydrocarbyl; R2 is selected from H, -O-hydrocarbyl, -S-hydrocarbyl, hydrocarbyl, -CN, -NO2, and halogens, R3 is selected from Formula (A), Formula (B), Formula (C), Formula (D) wherein each of R4, R5, R6, R7 and R8 is independently selected from H, -OH, hydrocarbyl, -O-hydrocarbyl, -COOH or an ester thereof, halocarbyl, -O-halocarbyl, acyl, -O-acyl, -NR29-acyl, -O-SO2NR19R20, -NR30R31, -NR32SO2R33, -CN, -NO2, and halogens, R9 is selected from H and hydrocarbyl, and each R29 to R33 is independently selected from H and hydrocarbyl; and wherein two or more of R4, R5, R6, R7, R8 and R9 may together form a ring; wherein when R1 is OH and R3 is of Formula (D), (i) at least one of R4, R5, R6, R7 and R8 is independently selected from halocarbyl, -O-halocarbyl, -O-acyl, -NR29-acyl, -O- SO2NR19R20, -NR30R31, -NR32SO2R33, -CN, and halogens, or (ii) two or more of R4, R5, R6, R7 and R8 together form a ring, or (iii) at least three of R4, R5, R6, R7 and R8 are independently selected from -OH, hydrocarbyl, -O-hydrocarbyl, halocarbyl, -O-halocarbyl, -O-acyl, -NR29-acyl, -O-SO2NR19R20, -NR30R31, -NR32SO2R33, -CN, -NO2, and halogens; wherein h is an optional bond, wherein G is CR24R25, wherein R24 and R25 independently selected from H, -OH, hydrocarbyl, -CN, -NO2, and halogens, or wherein when h is present G is CR24, wherein R24 is selected from H, -OH, hydrocarbyl, -CN, -NO2, and halogens; n is 0, 1 or 2, each D is independently selected from O, NR26 and CR27R28, wherein each R26 is independently selected from H and hydrocarbyl; and each R27 and R28 is independently selected from H, -OH, hydrocarbyl, -CN, -NO2, and halogens.
    [FR] La présente invention concerne un composé de formule (I) ou de formule (II) dans lesquelles A est choisi parmi CR10R11, -S(=O)2-, -NR12-, et C=O, R10 et R11 étant indépendamment choisis parmi H, -OH, un groupe hydrocarbyle, -CN, -NO2, et des atomes d'halogène, et R12 étant choisi parmi H et un groupe hydrocarbyle; B est choisi parmi (CR13R14)1-3, C=0, CR15R16C=O, -S(=O)2-, -NR17- et -NR18-C(=O)-, chacun de R13, R14, R15 et R16 étant indépendamment choisi parmi H, -OH, un groupe hydrocarbyle, -CN, -NO2, et des atomes d'halogène, R17
  • A Facile and Practical Synthesis of Capsazepine, a Vanilloid Receptor Antagonist
    作者:Jeewoo Lee、Jiyoun Lee
    DOI:10.1080/00397919908085886
    日期:1999.12.1
    A facile and practical synthesis of capsazepine, a vanilloid receptor antagonist, has been accomplished from isovanillin in 8 steps via an efficient intramolecular Mannich cyclization.
查看更多